Physician prescribing patterns of antihypertensives in diabetic patients before and after the implementation of Taiwan's guideline for the management of hypertension

Hon Yen Wu; Kuo Liong Chien; Kuan Yu Hung

doi:10.1016/j.jfma.2018.05.010

Physician prescribing patterns of antihypertensives in diabetic patients before and after the implementation of Taiwan's guideline for the management of hypertension

Hon Yen Wu, Kuo Liong Chien, Kuan Yu Hung

研究成果: 雜誌貢獻 › 快報 › 同行評審

摘要

Dear Editor:
Most diabetic patients require antihypertensive drugs, and various guidelines for the management of hypertension have been published in recent years.1, 2, 3 The first edition of Taiwan's guideline for hypertension was launched in 20101 and provides many suggestions for physicians in Taiwan. This guideline recommends renin-angiotensin system (RAS) inhibitors as first-line monotherapy for diabetic patients.1 The guideline also suggests that RAS inhibitors should be combined with calcium channel blockers (CCBs) or diuretics if appropriate control of blood pressure is not achieved and that β-blockers should be avoided due to metabolic side effects.1

原文	英語
頁（從 - 到）	650-651
頁數	2
期刊	Journal of the Formosan Medical Association
卷	117
發行號	7
DOIs	https://doi.org/10.1016/j.jfma.2018.05.010
出版狀態	已發佈 - 7月 2018
對外發佈	是

ASJC Scopus subject areas

一般醫學

UN SDG

此研究成果有助於以下永續發展目標

存取文件

10.1016/j.jfma.2018.05.010

其它文件與鏈接

引用此

@article{12f1750e25e542aaa1f3b5d89f5b7f36,

title = "Physician prescribing patterns of antihypertensives in diabetic patients before and after the implementation of Taiwan's guideline for the management of hypertension",

abstract = "Dear Editor:Most diabetic patients require antihypertensive drugs, and various guidelines for the management of hypertension have been published in recent years.1, 2, 3 The first edition of Taiwan's guideline for hypertension was launched in 20101 and provides many suggestions for physicians in Taiwan. This guideline recommends renin-angiotensin system (RAS) inhibitors as first-line monotherapy for diabetic patients.1 The guideline also suggests that RAS inhibitors should be combined with calcium channel blockers (CCBs) or diuretics if appropriate control of blood pressure is not achieved and that β-blockers should be avoided due to metabolic side effects.1",

author = "Wu, {Hon Yen} and Chien, {Kuo Liong} and Hung, {Kuan Yu}",

note = "Funding Information: We thank Ms Mei-Ru Chen of the Far Eastern Memorial Hospital for her assistance in the statistical computations. This study was supported by research grants to Dr. Hon-Yen Wu from the National Health Research Institutes in Taiwan (NHRI-EX106-10510PC, NHRI-EX107-10510PC) and the Far Eastern Memorial Hospital in New Taipei City, Taiwan (FEMH-EX106-10510PC, FEMH-EX107-10510PC). The interpretations presented in this study are those of the authors and do not represent the views of the National Health Insurance Administration or the National Health Research Institutes in Taiwan. Funding Information: We thank Ms Mei-Ru Chen of the Far Eastern Memorial Hospital for her assistance in the statistical computations. This study was supported by research grants to Dr. Hon-Yen Wu from the National Health Research Institutes in Taiwan ( NHRI-EX106-10510PC , NHRI-EX107-10510PC ) and the Far Eastern Memorial Hospital in New Taipei City, Taiwan ( FEMH-EX106-10510PC , FEMH-EX107-10510PC ). The interpretations presented in this study are those of the authors and do not represent the views of the National Health Insurance Administration or the National Health Research Institutes in Taiwan.",

year = "2018",

month = jul,

doi = "10.1016/j.jfma.2018.05.010",

language = "English",

volume = "117",

pages = "650--651",

journal = "Journal of the Formosan Medical Association",

issn = "0929-6646",

publisher = "Elsevier B.V.",

number = "7",

}

TY - JOUR

T1 - Physician prescribing patterns of antihypertensives in diabetic patients before and after the implementation of Taiwan's guideline for the management of hypertension

AU - Wu, Hon Yen

AU - Chien, Kuo Liong

AU - Hung, Kuan Yu

N1 - Funding Information: We thank Ms Mei-Ru Chen of the Far Eastern Memorial Hospital for her assistance in the statistical computations. This study was supported by research grants to Dr. Hon-Yen Wu from the National Health Research Institutes in Taiwan (NHRI-EX106-10510PC, NHRI-EX107-10510PC) and the Far Eastern Memorial Hospital in New Taipei City, Taiwan (FEMH-EX106-10510PC, FEMH-EX107-10510PC). The interpretations presented in this study are those of the authors and do not represent the views of the National Health Insurance Administration or the National Health Research Institutes in Taiwan. Funding Information: We thank Ms Mei-Ru Chen of the Far Eastern Memorial Hospital for her assistance in the statistical computations. This study was supported by research grants to Dr. Hon-Yen Wu from the National Health Research Institutes in Taiwan ( NHRI-EX106-10510PC , NHRI-EX107-10510PC ) and the Far Eastern Memorial Hospital in New Taipei City, Taiwan ( FEMH-EX106-10510PC , FEMH-EX107-10510PC ). The interpretations presented in this study are those of the authors and do not represent the views of the National Health Insurance Administration or the National Health Research Institutes in Taiwan.

PY - 2018/7

Y1 - 2018/7

N2 - Dear Editor:Most diabetic patients require antihypertensive drugs, and various guidelines for the management of hypertension have been published in recent years.1, 2, 3 The first edition of Taiwan's guideline for hypertension was launched in 20101 and provides many suggestions for physicians in Taiwan. This guideline recommends renin-angiotensin system (RAS) inhibitors as first-line monotherapy for diabetic patients.1 The guideline also suggests that RAS inhibitors should be combined with calcium channel blockers (CCBs) or diuretics if appropriate control of blood pressure is not achieved and that β-blockers should be avoided due to metabolic side effects.1

AB - Dear Editor:Most diabetic patients require antihypertensive drugs, and various guidelines for the management of hypertension have been published in recent years.1, 2, 3 The first edition of Taiwan's guideline for hypertension was launched in 20101 and provides many suggestions for physicians in Taiwan. This guideline recommends renin-angiotensin system (RAS) inhibitors as first-line monotherapy for diabetic patients.1 The guideline also suggests that RAS inhibitors should be combined with calcium channel blockers (CCBs) or diuretics if appropriate control of blood pressure is not achieved and that β-blockers should be avoided due to metabolic side effects.1

UR - http://www.scopus.com/inward/record.url?scp=85048731830&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048731830&partnerID=8YFLogxK

U2 - 10.1016/j.jfma.2018.05.010

DO - 10.1016/j.jfma.2018.05.010

M3 - Letter

C2 - 29804732

AN - SCOPUS:85048731830

SN - 0929-6646

VL - 117

SP - 650

EP - 651

JO - Journal of the Formosan Medical Association

JF - Journal of the Formosan Medical Association

IS - 7

ER -

Physician prescribing patterns of antihypertensives in diabetic patients before and after the implementation of Taiwan's guideline for the management of hypertension

摘要

ASJC Scopus subject areas

UN SDG

存取文件

其它文件與鏈接

指紋

引用此